Compare LINK & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LINK | PLUR |
|---|---|---|
| Founded | 1984 | 2001 |
| Country | United States | Israel |
| Employees | N/A | 142 |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.5M | 36.3M |
| IPO Year | 2007 | 2001 |
| Metric | LINK | PLUR |
|---|---|---|
| Price | $4.64 | $2.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $8.67 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 73.0K | 9.7K |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.83 | 10.78 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $11,890,000.00 | $1,336,000.00 |
| Revenue This Year | $43.26 | $97.38 |
| Revenue Next Year | $19.16 | $293.97 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 1.81 | ★ 309.82 |
| 52 Week Low | $2.66 | $2.22 |
| 52 Week High | $15.15 | $5.96 |
| Indicator | LINK | PLUR |
|---|---|---|
| Relative Strength Index (RSI) | 73.22 | 29.72 |
| Support Level | $3.40 | N/A |
| Resistance Level | $10.55 | $3.49 |
| Average True Range (ATR) | 0.44 | 0.27 |
| MACD | 0.12 | -0.09 |
| Stochastic Oscillator | 97.38 | 22.75 |
Interlink Electronics Inc is a sensor and printed electronics company operating in two principal sensor technology divisions: force/touch sensors, and gas and environmental sensors. It designs, develops, manufactures and sells a range of force-sensing and gas-sensing technologies that incorporate its proprietary materials technology, firmware and software into a portfolio of standard sensor-based products and custom sensor system solutions. Its force-sensing products and solutions include sensor components, subassemblies, modules products that support effective, efficient cursor control and novel three-dimensional user inputs. Its Human Machine Interface technology platforms are deployed in a wide range of markets including consumer electronics, automotive, industrial, and medical.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.